News | January 22, 2022
USFDA expands use of Remdesivir for Covid-19
Previously, the use of the drug was limited to patients requiring hospitalization
Previously, the use of the drug was limited to patients requiring hospitalization
Topline results from the randomized EMPATHY Part A study in acute Covid-19 ambulatory patients comparing single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs. placebo, met the primary endpoint of viral load reduction over eight days
Celltrion plans to provide dual treatment options for COVID-19; Regkirona for hospitalised patients and a nebulised cocktail therapy (CT-P63 in combination with Regkirona) for at- home settings
Trastuzumab is monoclonal antibody used to treat human epidermal growth factor receptor 2 positive (HER2+) breast cancer and metastatic gastric cancers
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
The final data from the trial showed sotrovimab reduces hospitalisation and risk of death by 79% in adults with mild-to-moderate Covid-19 who are at high risk of progression to severe disease
The Akovaz brand and generic market had U.S. sales of approximately US $ 67.5 million MAT for the most recent twelve months ending in August 2021
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
PPH is associated with almost 20 per cent of maternal mortality in India
The approval is based on a multi-centre, single-arm, open-label pivotal clinical trial
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
